# Greece Bio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/greece-bio

- Industry: Biotechnology
- Headquarters: Foshan, China
- Latest round: Angel (Mar 5, 2026)
- Investors on record: 2

## About

Based in Foshan, China, and founded in 2022, Gulf (Foshan) Biotechnology Co., Ltd., trading as Greece Bio,  is a high-tech enterprise focusing on the research and industrialization of marine bioactive materials, with applications already realized in the medical, cosmetic, food, and agricultural fields.  In March 2026, Greece Bio closed Angel funding led by Triwise Capital, with participation from National Innovation Center for High Performance Medical Devices and Jia Yi Investment.

The company specializes in their research and industrialization. Its technology has been applied in the medical, cosmetic, food, and agricultural sectors.

The company’s revenue is generated by providing bioactive materials.

## Funding rounds

- Angel, Mar 5, 2026 — Triwise Capital, National Innovation Center for High Performance Medical Devices
- Series A, Feb 9, 2026 — Triwise Capital

## Investors

- Triwise Capital (https://capitalatlas.ai/funds/triwise-capital) — Series A, Angel
- National Innovation Center for High Performance Medical Devices — Angel
